Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several cancer indications.
Curasight A/S has raised $3.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
Curasight A/S's investors include Seed Capital, PSV, Fenja Capital, Pentwater Capital Management, Curium International Trading.
Curasight A/S is headquartered in Copenhagen, Denmark.
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several cancer indications.
Curasight A/S is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Curasight A/S — Funding & Investors." VCBacked, June 22, 2026, https://www.vcbacked.co/company/curasight-as. Accessed August 14, 2026.
VCBacked. (2026). Curasight A/S — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/curasight-as
{{cite web |title=Curasight A/S — Funding & Investors |url=https://www.vcbacked.co/company/curasight-as |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated